Mark De Rosch - 28 Oct 2021 Form 3 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Operating Officer
Signature
/s/ Julie Feder
Issuer symbol
AURA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
3
Filing time
28 Oct 2021, 20:23:40 UTC
Next filing
02 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AURA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 56,620 $5.48 Direct F1
holding AURA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 125,547 $5.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of Shares on the first anniversary of March 15, 2021 with the remainder vesting in 36 substantially equal monthly installments.
F2 The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following June 28, 2021.